… 6-20 years-old) in Uganda [7]. In the Uganda follow-up study covering two malaria peak
seasons, encouraging … A phase Ib study in Burkina Faso is now in progress (Pan African Clinical …

… n = 200) and Uganda (n = 257) were randomized in a 1:1 … trial cohort investigating these
hypotheses may inform improved design of future GMZ2 and other blood stage malaria vaccines…

… /CpG is a recombinant blood-stage malaria vaccine candidate based on … in larger Phase
2/3 trials or with long-term follow-up. … The high baseline antibody titres in Ugandan adults were …

… not develop malaria during follow-up … malaria vaccine with or without a booster dose in
infants and children in Africa: final results of a phase 3, individually randomised, controlled trial …

… the phase I trial in Uganda justified the conduct of a trial in … trials, BK-SE36 is a promising
blood-stage malaria vaccine … Chitnis) during the trial and follow up study are much appreciated. …

… in the development of malaria vaccines that target the blood stage of malaria parasites. …
Although the Ugandan study was not designed to evaluate efficacy of the vaccine, follow-up of …

… of blood-stage infection and clinical malaria over 12 months of follow-up with the
acknowledgement that vaccines … This trend was observed in a follow-up study which also reported …

… Phase Ib was developed in two stages in Uganda; the first … An additional randomized,
double-blind, phase Ib study … both trials were related to sample size, short/limited follow-up…

… stages in the liver, which are not tackled by the blood-stage … month follow-up had an efficacy
of 35% for all malaria events … trials on RTS,S/AS01 vaccine led to a Phase III randomized …

… , phase Ib clinical trial with a single-blind follow-up phase … with BK-SE36 blood-stage malaria
vaccine candidate in 12-60 … ) during the trial and follow-up study are much appreciated. We …